Immatics US, Inc. et al v. Immutics, Inc., candc:3:2020cv02726

Medical and scientific research for others in the fields of diagnosis and treatment of cancer;

medical research services, namely, conducting clinical trials for others in the fields of cancer;

medical testing services; medical services, namely, diagnosis and treatment of cancer;

Pharmaceutical products, namely, biological and chemical preparations for use against proliferating diseases and diagnostic reagents for medical use; synthetic peptides and proteins for pharmaceutical purposes; peptides and proteins for medical, diagnostic or therapeutic purposes, namely, the treatment of cancer; in-vitro diagnostic reagents for medical use [ ; in-vivo diagnostic reagents for medical use ];

Scientific research in the fields of chemistry, biochemistry or biology; laboratory research in the field of biology, biochemistry or chemistry; performance of biological, biochemical or chemical analyses; medical and scientific research in the field of cancer treatment and diagnostics; biological and biochemical research and analysis;

Medical examination services and medical clinical examination services in the field of cancer treatment and diagnosis;

Pharmaceutical products, namely, biological and chemical preparations for use against proliferating diseases and diagnostic reagents for medical use; synthetic peptides, proteins and cells for pharmaceutical purposes; peptides, proteins and cells for medical, diagnostic or therapeutic purposes, namely, the treatment of cancer; in-vitro diagnostic reagents for medical use [ ; in-vivo diagnostic reagents for medical use ];

Scientific research in the fields of chemistry, biochemistry or biology; laboratory research in the field of biology, biochemistry or chemistry; performance of biological, biochemical or chemical analyses; medical and scientific research in the field of cancer treatment and diagnostics; biological and biochemical research and analysis;

Medical examination services and medical clinical examination services in the field of cancer treatment and diagnosis;

Medical and pharmaceutical products, namely, pharmaceutical preparations for the treatment of oncological, anti-viral, anti-bacterial and autoimmunity disorders and diseases and natural remedy preparations for the treatment of oncological, viral, bacterial and autoimmunity disorders and diseases; diagnostic reagents for medical purposes; synthetic peptides, binding proteins and living cells for medical, diagnostic and therapeutic purposes, in particular for cancer therapy;

Medical research and pharmacological research services; conducting research and clinical trials for others relating to the use and the engineering of t-cells and cancer treatment and therapy; scientific research in the field of chemistry, biochemistry and biology; scientific laboratory services, namely, biological, biochemical and chemical laboratory services; biological, biochemical and chemical analysis; medical and scientific research in the field of cancer diagnosis; scientific laboratory services, namely, biological and biochemical laboratory services; biological and biochemical research, development and analysis services;

Medical services and pharmaceutical services, namely, medical diagnosis and medical diagnosis through the use of pharmacologicals of oncological, viral, bacterial, and autoimmune diseases; dispensing of pharmaceuticals, namely, providing medical supply for therapy, in particular supply of synthetic peptides, binding proteins and living cells for cancer therapy; medical diagnosis of cancer;